OPKO Health sells NGENLA growth hormone treatment, Rayaldee kidney disease treatment and specialty lab tests for doctors and patients. It last closed at $1.57 on Nov 20, down 2.48% on the day. The next earnings report for OPK is expected around Thu, Feb 25, 2027, after the close. For the quarter ended Sep 2026, OPK reported EPS of -$0.07 on revenue of $65.4M, with revenue up 15.9% from a year ago. Over its last 8 reports the stock moved an average of 7.6% the session after earnings. Over the last 12 months OPK insiders bought $1.6M of stock on the open market and sold $25K, according to SEC Form 4 filings.
AI Auto Pilots
Is OPK in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold OPK.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on OPKStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
OPK · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend
The stock is 7% below its 20 day and 2% below its 50 day average. It is 13% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 43). The nearest support is the Pivot S1 at $1.54, and the nearest resistance the Pivot at $1.58.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 5.4%/day
Key levels
$1.8652 week high+18.5%
$1.6720 day average+6.4%
$1.6150 day average+2.5%
$1.61Pivot R1+2.5%
$1.61Swing high (Jun 26)+2.5%
$1.58Pivot+0.6%
$1.57Last close
$1.54Pivot S1−1.9%
$1.50100 day average−4.5%
$1.48Swing low (Jun 30)−5.7%
$1.37200 day average−12.7%
$0.9852 week low−37.6%
Indicators
RSI (14)
42.62
Middle of its range
Neutral
MACD
0.01
Below its signal line
Bearish
Stochastic
18.4
Near the bottom of its range
Oversold
ADX (14)
22.1
Weak trend
Williams %R
-92.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-145.9
Oversold below −100, overbought above 100
Oversold
Rate of change
−9.3%
Change over 10 sessions
Bearish
ATR (14)
$0.09
Typical daily range, 5.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
Turning up
Short trendBullish
Long trendNeutral
MomentumImproving
StretchNormal
VolatilityNormal, 11.3%/day
Key levels
$1.8652 week high+18.5%
$1.6720 day average+6.4%
$1.6150 day average+2.5%
$1.61Pivot R1+2.5%
$1.61Swing high (Jun 26)+2.5%
$1.58Pivot+0.6%
$1.57Last close
$1.54Pivot S1−1.9%
$1.50100 day average−4.5%
$1.48Swing low (Jun 30)−5.7%
$1.37200 day average−12.7%
$0.9852 week low−37.6%
Indicators
RSI (14)
53.56
Middle of its range
Neutral
MACD
0.08
Above its signal line
Bullish
Stochastic
64.5
Middle of its range
Neutral
ADX (14)
31.0
Trending up
Williams %R
-51.8
Oversold below −80, overbought above −20
Neutral
CCI (20)
49.7
Oversold below −100, overbought above 100
Neutral
Rate of change
+0.0%
Change over 10 sessions
Bearish
ATR (14)
$0.18
Typical daily range, 11.3% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for OPK
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how OPK did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow OPK usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for OPKHow many large options trades hit OPK, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in OPK in the last 90 days.
From SEC Form 4 filings by OPK's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether OPK is in one of them and how their past OPK trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Opko Health
OPKO Health is a healthcare company based in Miami, Florida. It sells NGENLA, a weekly growth hormone treatment for children, and Rayaldee, a treatment for secondary hyperparathyroidism in adults with chronic kidney disease. Its laboratory business provides clinical and women's health testing in New York and New Jersey, along with the 4Kscore prostate cancer test, which is offered across the United States. The company is also developing therapies for cancer and infectious disease.